The role of intravesical chemotherapy in decreasing tumor recurrence is well established. No consensus has, however, been reached on the best drug schedule, dose, or timing of the instillation.

Overall 5-year and 10-year survival was 38% and 29%, respectively. Patients who received intravesical chemotherapy (mitomycin C, doxorubicin or pirarubicin), whether immediately after surgery or ...

One of the most promising new strategies for NMIBC is the combination of intravesical chemotherapy drugs used as sequential ...

The role of intravesical chemotherapy in decreasing tumor recurrence is well established. No consensus has, however, been reached on the best drug schedule, dose, or timing of the instillation.

J&J, meanwhile, is also testing Balversa in the THOR-2 study, which is comparing the drug to the investigator's choice of intravesical chemotherapy in patients with high-risk non–muscle-invasive ...

Given the recent data, we sought to formally describe our experience with and evaluate the safety of intravesical instillation of cytotoxic chemotherapy at the time of nephroureterectomy.

Ferring activates first sites in a three-arm study of ADSTILADRIN as a monotherapy or in combination with chemotherapy or an ...